Featured Research

from universities, journals, and other organizations

New Bone Marrow Transplantation Technique Promises Safer, More Effective Cancer Treatments

Date:
July 20, 1999
Source:
University Of Pennsylvania Medical Center
Summary:
Researchers at the University of Pennsylvania Medical Center have devised a safer, more effective strategy for bone marrow transplantation that does not require the use of drugs that globally suppress the immune system.

Researchers at the University of Pennsylvania Medical Center have devised a safer, more effective strategy for bone marrow transplantation that does not require the use of drugs that globally suppress the immune system. A report on the new technique, demonstrated in mice, appears in the July 16 issue of Science.

Transplantation of bone marrow, which gives rise to all types of blood cells in the body, including immune system cells, is useful in treating cancers of the blood and inherited blood disorders. Because it is the source of the cells that constitute the immune system, however, bone marrow transplantation sometimes leads to a potentially quite serious condition called graft-versus-host disease, or GVHD, in which T cells produced by the donor marrow attack the host, i.e., the patient receiving the transplant.

For this reason, powerful drugs that suppress the immune system, primarily by paralyzing T cells, are given to bone marrow transplant recipients to control GVHD. Immune suppression carries its own costs, however, leaving the patient vulnerable to infections and other problems.

The new approach used by the Penn scientists involves inactivating a subset of immune-system cells in the transplant recipient called antigen-presenting cells, or APCs. Although the patient's existing bone marrow is destroyed prior to transplantation - largely to preclude GVHD - APCs originating from that marrow continue to circulate in the patient's blood. Those APCs serve as the trigger for T cells produced by the newly received bone marrow to attack cells in the patient. When these APCs were disabled, however, GVHD was entirely prevented.

"Most techniques for immunosuppression are based upon paralyzing T cells," says Stephen G. Emerson, MD, chief of the division of hematology-oncology, professor of medicine, and senior author on the report. "They're global, and they have serious limitations. Targeting antigen-presenting cells, however, provides a different cell type to focus on for immunosuppression, with the idea of inhibiting host antigen presentation and stopping the process of immune stimulation right at the beginning."

The lead author on the report is Warren D. Shlomchik. The other Penn-based authors are Matthew S. Couzens and Cheng Bi Tang. The coauthors affiliated with Yale University are Jennifer McNiff, Marie E. Robert, Jinli Liu, and Mark J. Shlomchik.


Story Source:

The above story is based on materials provided by University Of Pennsylvania Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

University Of Pennsylvania Medical Center. "New Bone Marrow Transplantation Technique Promises Safer, More Effective Cancer Treatments." ScienceDaily. ScienceDaily, 20 July 1999. <www.sciencedaily.com/releases/1999/07/990720083803.htm>.
University Of Pennsylvania Medical Center. (1999, July 20). New Bone Marrow Transplantation Technique Promises Safer, More Effective Cancer Treatments. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/1999/07/990720083803.htm
University Of Pennsylvania Medical Center. "New Bone Marrow Transplantation Technique Promises Safer, More Effective Cancer Treatments." ScienceDaily. www.sciencedaily.com/releases/1999/07/990720083803.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

How Nigeria Beat Its Ebola Outbreak

How Nigeria Beat Its Ebola Outbreak

Newsy (Oct. 20, 2014) The World Health Organization has declared Nigeria free of Ebola. Health experts credit a bit of luck and the government's initial response. Video provided by Newsy
Powered by NewsLook.com
Another Study Suggests Viagra Is Good For The Heart

Another Study Suggests Viagra Is Good For The Heart

Newsy (Oct. 20, 2014) An ingredient in erectile-dysfunction medications such as Viagra could improve heart function. Perhaps not surprising, given Viagra's history. Video provided by Newsy
Powered by NewsLook.com
Ebola Worries End for Dozens on U.S. Watch Lists

Ebola Worries End for Dozens on U.S. Watch Lists

Reuters - US Online Video (Oct. 20, 2014) Forty-three people who had contact with Thomas Eric Duncan, the first person diagnosed with Ebola in the U.S., were cleared overnight of twice-daily monitoring after 21 days of showing no symptoms. Rough Cut (no reporter narration). Video provided by Reuters
Powered by NewsLook.com
Beijing Marathon Runners Brave Hazardous Air Pollution

Beijing Marathon Runners Brave Hazardous Air Pollution

AFP (Oct. 19, 2014) Tens of thousands of runners battled thick smog at the Beijing Marathon on Sunday, with some donning masks as the levels of PM2.5 small pollutant particles soared to 16 times the maximum recommended level. Duration: 00:54 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins